Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK LIFE SCIENCES Plunges 5%; BSE HEALTHCARE Index Up 0.6%
Fri, 25 Oct 9:28

GLENMARK LIFE SCIENCES Plunges 5%; BSE HEALTHCARE Index Up 0.6%Image source: phive2015/www.istockphoto.com

GLENMARK LIFE SCIENCES share price has plunged 5% and is presently trading at Rs 991.7.

Meanwhile, the BSE HEALTHCARE index is at 43,143.5 (up 0.6%).

Among the top losers in the BSE HEALTHCARE index today are Procter & Gamble Health (down 2.1%) and CAPLIN POINT (down 1.1%).

LAURUS LABS (up 2.8%) and ASTER DM HEALTHCARE (up 2.5%) are among the top gainers today.

Over the last one year, GLENMARK LIFE SCIENCES has moved up from Rs 619.8 to Rs 991.7, registering a gain of Rs 371.9 (up 60.0%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,503.7 to 43,143.5, registering a gain of 56.9% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 206.8%), Glenmark Pharma (up 123.9%) and SUVEN PHARMACEUTICALS (up 123.2%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 80,109.2 (up 0.1%).

The top gainers among the BSE Sensex today are ITC (up 3.3%) and Axis Bank (up 2.5%). The most traded stocks in the BSE Sensex are Indusind Bank and ITC.

In the meantime, NSE Nifty is at 24,393.2 . Indusind Bank and NTPC are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 64,571.9 to 80,109.2, registering a gain of 15,537.3 points (up 24.1%).

GLENMARK LIFE SCIENCES Financial Update...

GLENMARK LIFE SCIENCES net profit fell 19.7% YoY to Rs 953 million for the quarter ended September 2024, compared to a profit of Rs 1,187 million a year ago. Net sales declined 14.9% to Rs 5,069 million during the period as against Rs 5,954 million in July-September 2023.

For the year ended March 2024, GLENMARK LIFE SCIENCES reported 0.8% increase in net profit to Rs 4,709 million compared to net profit of Rs 4,670 million during FY23. Revenue of the company grew 5.6% to Rs 22,832 million during FY24.

The current Price to earnings ratio of GLENMARK LIFE SCIENCES, based on rolling 12 month earnings, stands at 28.7.


Equitymaster requests your view! Post a comment on "GLENMARK LIFE SCIENCES Plunges 5%; BSE HEALTHCARE Index Up 0.6%". Click here!